Noninfectious Causes of Fever in 128 Patients with Systemic Lupus Erythematosus
Background: This study aimed to explore the clinical characteristics of noninfectious fever in patients with systemic lupus erythematosus (SLE) and the underlying causes through multivariate analysis.
Methods: Clinical data of 128 patients with SLE who were admitted to Affiliated Hospital of Nanjing University of TCM, Nanjing 210029, P.R. China from January 2015 to December 2017 were retrospectively analyzed.
Results: The following factors were closely associated with fever: patient age, treatment history, SLEDAI score, enlarged liver, spleen and lymph nodes, low hemoglobin, leukopenia, CRP, complement C3, albumin, anti-dsDNA antibody, glucocorticoids, and cyclophosphamide. Multivariate logistic regression analysis showed that factors, such as enlarged liver, spleen and lymph nodes, digestive system involvement, low hemoglobin, leukopenia, CRP, decreased albumin, anti-dsDNA antibody, glucocorticoids and cyclophosphamide, were closely associated with noninfectious fever in SLE.
Conclusion: Noninfectious fever is a common clinical manifestation of SLE. Factors, such as enlarged liver, spleen and lymph nodes, digestive system involvement, low hemoglobin, leukopenia, CRP, decreased albumin, anti-dsDNA antibody, glucocorticoids, and cyclophosphamide, were independent risk factors for noninfectious fever in SLE.
2. Bernatsky S, Boivin JF, Joseph L et al (2006). Mortality in systemic lupus erythematosus. Arthritis Rheum, 54: 2550-2557.
3. Jung JY, Suh CH (2017). Infection in sys-temic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med, 32:429-438.
4. Liu LN, Wang P, Guan SY et al (2017). Comparison of plasma/serum levels of procalcitonin between infection and fe-brile disease flare in patients with system-ic lupus erythematosus: a meta-analysis. Rheumatol Int, 37:1991-1998.
5. Vasquez-Canizares N, Wahezi D, Putterman C (2017). Diagnostic and prognostic tests in systemic lupus erythematosus. Best Pract Res Clin Rheumatol, 31:351-363.
6. Alsaleh J, Jassim V, Elsayed M, Saleh N, Harb D (2008). Clinical and immunologi-cal manifestations in 151 SLE patients living in Dubai. Lupus, 17: 62-66.
7. Bosch X, Guilabert A, Pallarés L et al (2006). Infections in systemic lupus ery-themaosus: a prospective and controlled study of 110 patients. Lupus, 15: 584-589.
8. Kang I, Park SH (2003). Infectious compli-cations in SLE after immunosuppressive therapies. Curr Opin Rheumatol, 15: 528-534.
9. Timlin H, Syed A, Haque U, Adler B, Law G, Machireddy K, Manno R (2018). Fevers in Adult Lupus Patients. Cureus, 10: e2098.
10. Apostolopoulos D, Morand EF (2017). It hasn't gone away: the problem of gluco-corticoid use in lupus remains. Rheumatolo-gy (Oxford), 56: i114-i122.
11. Rovin BH, Tang Y, Sun J et al (2005). Clini-cal significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int, 68: 747-759.
12. Alrayes H, Alswailem R, Arfin M, Sobki S, Rizvi S and Tariq M (2007). Systemic lu-puserythematosus and infections: a retro-spective study in Saudis. Lupus, 16: 755-763.
|Issue||Vol 48 No 1 (2019)|
|Lupus erythematosus Systemic; Fever Risk factors Retrospective study|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|